Zuellig Denies Proposal on Inventory Returns from Its Associate Wholesalers

Published: 2005-02-25 06:59:00

Updated: 2005-02-25 06:59:00

In the third round of negotiations on improving contractual terms and conditions for the pharmaceutical wholesale distribution by Zuellig Pharma Korea (ZPK), the representatives from the Seoul Pharmaceutical Association (SPA) and ZPK were not able to reach an agreement on certain return provision...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK